Aims: It is very important to evaluate patients presenting with chest pain in terms of major adverse cardiovascular events (MACE) and many risk scoring systems have been developed for this purpose. In this study, we aimed to evaluate the MACE prediction performance of the newly developed symptoms, history of vascular disease, electrocardiography, age and troponin (SVEAT) score for patients presenting with chest pain.
Methods: This study was designed as a retrospective observational clinical trial. MACE occurring within 30 days; Myocardial infarction (MI), percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) and sudden cardiac death were considered the primary endpoints of the study. Patients over 18 years of age presenting with chest pain were included in the study. Patients with ST segment elevation on electrocardiography (ECG), hemodynamic instability and traumatic chest pain were excluded.
Results: The study included 557 patients and the mean age was 54.52±12.56 and the age distribution range was 23-95. Significant results for SVEAT score (AUC:0.988, 95%CI:0.978-0.997, p<0.001) and history, electrocardiography, age, risk factors and troponin (HEART) score (AUC:0.960, 95%CI:0.942-0.979, p<0.001) were obtained from ROC analysis of the effect of SVEAT and HEART scores on MACE.
Conclusion: The newly developed SVEAT score was superior to the HEART score in predicting adverse negative cardiac events in patients presenting with chest pain.
Aims: It is very important to evaluate patients presenting with chest pain in terms of major adverse cardiovascular events (MACE) and many risk scoring systems have been developed for this purpose. In this study, we aimed to evaluate the MACE prediction performance of the newly developed symptoms, history of vascular disease, electrocardiography, age and troponin (SVEAT) score for patients presenting with chest pain.
Methods: This study was designed as a retrospective observational clinical trial. MACE occurring within 30 days; Myocardial infarction (MI), percutaneous coronary intervention (PCI), coronary artery bypass graft (CABG) and sudden cardiac death were considered the primary endpoints of the study. Patients over 18 years of age presenting with chest pain were included in the study. Patients with ST segment elevation on electrocardiography (ECG), hemodynamic instability and traumatic chest pain were excluded.
Results: The study included 557 patients and the mean age was 54.52±12.56 and the age distribution range was 23-95. Significant results for SVEAT score (AUC:0.988, 95%CI:0.978-0.997, p<0.001) and history, electrocardiography, age, risk factors and troponin (HEART) score (AUC:0.960, 95%CI:0.942-0.979, p<0.001) were obtained from ROC analysis of the effect of SVEAT and HEART scores on MACE.
Conclusion: The newly developed SVEAT score was superior to the HEART score in predicting adverse negative cardiac events in patients presenting with chest pain.
The protocol for this study was approved by the the Local Ethics Committee of City Hospital (AEŞH-EK1-655-2023) and written informed consent was waived due to the retrospective nature of the study.
| Primary Language | English |
|---|---|
| Subjects | Emergency Medicine |
| Journal Section | Research Article |
| Authors | |
| Submission Date | May 27, 2025 |
| Acceptance Date | July 22, 2025 |
| Publication Date | September 15, 2025 |
| Published in Issue | Year 2025 Volume: 7 Issue: 5 |
TR DİZİN ULAKBİM and International Indexes (1b)
Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS]
Note: Our journal is not WOS indexed and therefore is not classified as Q.
You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/3449/file/4924/show
Journal Indexes and Platforms:
TR Dizin ULAKBİM, Google Scholar, Crossref, Worldcat (OCLC), DRJI, EuroPub, OpenAIRE, Turkiye Citation Index, Turk Medline, ROAD, ICI World of Journal's, Index Copernicus, ASOS Index, General Impact Factor, Scilit.The indexes of the journal's are;
The platforms of the journal's are;
|
The indexes/platforms of the journal are;
TR Dizin Ulakbim, Crossref (DOI), Google Scholar, EuroPub, Directory of Research Journal İndexing (DRJI), Worldcat (OCLC), OpenAIRE, ASOS Index, ROAD, Turkiye Citation Index, ICI World of Journal's, Index Copernicus, Turk Medline, General Impact Factor, Scilit
Journal articles are evaluated as "Double-Blind Peer Review"
All articles published in this journal are licensed under a Creative Commons Attribution 4.0 International License (CC BY NC ND)